Skip to content

13F-HR filed by Troluce Capital Advisors LLC

Troluce Capital Advisors LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 30 holding rows worth $422,532,323.

Accession
0001892688-25-000153
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 30 entries on the cover page, a total value of $422,532,323 stated on the cover page (in dollars after the unit check, H1), rows summing to $422,532,323 with VALUE read as dollars as filed, 13F file number 028-21809. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
FLUOR CORP343412102COM1,300,000$66,651,000dollars as filed
NUSCALE PWR CORP CL A COM67079K100Stock1,015,000$40,153,400dollars as filedcall
CAPITAL ONE FINL CORP14040H105COM169,400$36,041,544dollars as filed
SKECHERS U S A INC830566105CL A548,700$34,622,970dollars as filedcall
CAPITAL ONE FINL CORP14040H105COM150,000$31,914,000dollars as filedcall
GOLAR LNG LTDG9456A100SHS750,000$30,892,500dollars as filedcall
SPY78462F103SHS50,000$30,882,500dollars as filedput
KENVUE INC49177J102COM950,000$19,883,500dollars as filed
AMCOR PLCG0250X107ORD1,863,400$17,124,646dollars as filedcall
WESTERN DIGITAL CORP958102105COM255,150$16,327,049dollars as filed
FLUOR CORP343412102COM300,000$15,381,000dollars as filedput
MIRION TECHNOLOGIES INC60471A101COM CL A600,000$12,918,000dollars as filed
AMCOR PLCG0250X107ORD1,350,000$12,406,500dollars as filed
ROBLOX CORP CL A771049103Stock100,000$10,520,000dollars as filedput
AMRIZE LTD SHSH2927K103Stock210,000$10,405,500dollars as filed
UnitedHealth Group Inc91324P102COM20,000$6,239,400dollars as filedcall
VESTIS CORPORATION29430C102COM SHS1,000,000$5,730,000dollars as filedput
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR30,000$5,178,000dollars as filed
HUDSON PAC PPTYS INC444097109COM1,350,000$3,699,000dollars as filed
MERUS N VN5749R100COM70,000$3,682,000dollars as filed
ROIVANT SCIENCES LTDG76279101SHS250,000$2,817,500dollars as filed
SURGERY PARTNERS INC86881A100COM100,000$2,223,000dollars as filed
KENVUE INC49177J102COM100,000$2,093,000dollars as filedcall
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock85,791$1,045,792dollars as filed
VESTIS CORPORATION29430C102COM SHS179,105$1,026,272dollars as filed
BIT DIGITAL INCG1144A105COMMON STOCK350,000$766,500dollars as filed
DIVERSIFIED HEALTHCARE TR25525P107COM SH BEN INT200,000$716,000dollars as filed
USA RARE EARTH INC COM91733P107Stock50,000$547,500dollars as filedcall
CORE SCIENTIFIC INC NEW21874A106COM25,000$426,750dollars as filed
Tscan Therapeutics Inc89854M101COM150,000$217,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001892688-25-000153this filing2025-08-14acceptance time not in the bulk data set